Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galectin Therapeutics Inc (NASDAQ:GALT)

2.49
Delayed Data
As of Dec 13
 +0.08 / +3.32%
Today’s Change
0.88
Today|||52-Week Range
3.68
+154.13%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Freeman Kevin D
Director
Buy12/07/20178,000$1.63$13.0K+23.88%
Rubin Marc
Director
Buy12/08/20177,000$1.85$13.0K+2.47%
Zucconi Theodore Daniel
Director
Buy5/23/20171,000$2.27$2.3K+6.41%
Freeman Kevin D
Director
Buy12/07/2017400$1.64$656.00+23.88%